从2003年开始,中科院、广东省和广州市瞄准新兴的生物制药领域,三方各投入一个亿,共建中科院广州生物医药与健康研究院。研究院以国家健康和生物医药战略需求为导向,以国际前沿领域研究、高水平核心技术创新与集成为核心,提高生物 Since 2003, the Chinese Academy of Sciences, Guangdong Province and Guangzhou aim at the emerging field of bio-pharmaceuticals. Each of the three parties has invested one billion yuan to build the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences. The Institute is guided by the strategic needs of national health and biomedicine, with research in the international frontiers and high-level core technology innovation and integration as its core